C. Bergeron

1.6k total citations
58 papers, 1.0k citations indexed

About

C. Bergeron is a scholar working on Epidemiology, Reproductive Medicine and Surgery. According to data from OpenAlex, C. Bergeron has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 13 papers in Reproductive Medicine and 11 papers in Surgery. Recurrent topics in C. Bergeron's work include Cervical Cancer and HPV Research (26 papers), Endometriosis Research and Treatment (11 papers) and Estrogen and related hormone effects (9 papers). C. Bergeron is often cited by papers focused on Cervical Cancer and HPV Research (26 papers), Endometriosis Research and Treatment (11 papers) and Estrogen and related hormone effects (9 papers). C. Bergeron collaborates with scholars based in France, Canada and United Kingdom. C. Bergeron's co-authors include Alex Ferenczy, R M Richart, G. Shyamala, R. Frydman, Marc Arbyn, Ulrich Schenck, Johan Bulten, P J Klinkhamer, Amanda Herbert and Dominique de Ziegler and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the New York Academy of Sciences and British Journal of Cancer.

In The Last Decade

C. Bergeron

53 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bergeron France 17 501 269 218 212 192 58 1.0k
A Frega Italy 21 683 1.4× 233 0.9× 74 0.3× 444 2.1× 182 0.9× 85 1.3k
Liliana Aparecida Lucci De Angelo Andrade Brazil 15 343 0.7× 178 0.7× 77 0.4× 288 1.4× 131 0.7× 53 782
Inger Gustavsson Sweden 19 888 1.8× 181 0.7× 161 0.7× 341 1.6× 238 1.2× 44 1.3k
C. David Wrede Australia 20 988 2.0× 126 0.5× 66 0.3× 294 1.4× 761 4.0× 52 1.6k
Keith W.K. Lo Hong Kong 28 575 1.1× 136 0.5× 146 0.7× 291 1.4× 197 1.0× 45 1.8k
Barbara Winkler United States 20 901 1.8× 102 0.4× 129 0.6× 677 3.2× 343 1.8× 38 1.5k
K. S. Raju United Kingdom 18 398 0.8× 175 0.7× 104 0.5× 208 1.0× 125 0.7× 36 830
Willard A. Barnes United States 27 1.5k 2.9× 522 1.9× 282 1.3× 669 3.2× 507 2.6× 52 2.3k
Jens Einenkel Germany 22 407 0.8× 292 1.1× 64 0.3× 273 1.3× 390 2.0× 51 1.3k
Alfred I. Sherman United States 15 393 0.8× 312 1.2× 73 0.3× 279 1.3× 194 1.0× 41 1.2k

Countries citing papers authored by C. Bergeron

Since Specialization
Citations

This map shows the geographic impact of C. Bergeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bergeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bergeron more than expected).

Fields of papers citing papers by C. Bergeron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bergeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bergeron. The network helps show where C. Bergeron may publish in the future.

Co-authorship network of co-authors of C. Bergeron

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bergeron. A scholar is included among the top collaborators of C. Bergeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bergeron. C. Bergeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Camargo, Beatriz de, Harm van Tinteren, C. Bergeron, et al.. (2022). International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study. JCO Global Oncology. 8(8). e2100425–e2100425. 16 indexed citations
2.
Abramowitz, Laurent, M. Moyal‐Barracco, Nathalie Largeron, et al.. (2016). Epidemiology, Treatment Pathways and Costs of Cancers Potentially Related to HPV Infection in France. Value in Health. 19(7). A609–A610. 1 indexed citations
3.
Vassal, Gilles, Judith Landman‐Parker, André Baruchel, et al.. (2015). Multidisciplinarité et formation des spécialistes à l’oncologie et à l’hématologie maligne pédiatrique. Archives de Pédiatrie. 22(12). 1217–1222. 5 indexed citations
4.
Aynaud, Olivier, Bich-Tram Huynh, & C. Bergeron. (2012). Prévalence de lésions HPV-induites chez les hommes : étude à partir de 246 couples hétérosexuels. Gynécologie Obstétrique & Fertilité. 40(7-8). 406–410.
6.
Walter, Thomas, Frédérique Dijoud, Sophie Collardeau‐Frachon, et al.. (2010). Tumeurs stromales gastro-intestinales pédiatriques : à propos de trois cas et revue de la littérature. Gastroentérologie Clinique et Biologique. 34(6-7). 407–409.
7.
Lavoué, Vincent, C. Bergeron, D. Riethmuller, et al.. (2010). Un nouveau paradigme pour le dépistage du cancer du col utérin ?. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 39(2). 102–115. 2 indexed citations
8.
Lévêque, Jean, C. Bergeron, & J.-C. Boulanger. (2008). Méthode utilisée et questions abordées. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 37(1). S112–S113. 4 indexed citations
9.
Herbert, Amanda, C. Bergeron, H. Wiener, et al.. (2007). European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology. Cytopathology. 18(4). 213–219. 64 indexed citations
10.
Boulanger, J.-C., R. Fauvet, Yves Le Dréan, et al.. (2007). Histoire cytologique des cancers du col utérin diagnostiqués en France en 2006. Gynécologie Obstétrique & Fertilité. 35(9). 764–771. 23 indexed citations
11.
Bergeron, C., et al.. (2006). Coût du dépistage et de la prise en charge des lésions précancéreuses du col utérin en France. Gynécologie Obstétrique & Fertilité. 34(11). 1036–1042. 27 indexed citations
13.
Boulanger, J.-C. & C. Bergeron. (2005). Actualités en pathologie cervicale : l'Europe de la colposcopie. Gynécologie Obstétrique & Fertilité. 33(1-2). 50–54. 1 indexed citations
14.
Quéreux, C, Bruno Pornel, C. Bergeron, & Alex Ferenczy. (2005). Continuous combined hormone replacement therapy with 1 mg 17β-oestradiol and 5 mg dydrogesterone (Femoston®-conti): Endometrial safety and bleeding profile. Maturitas. 53(3). 299–305. 12 indexed citations
15.
Bergeron, C.. (2001). Place de la détection des papillomavirus humains dans le dépistage et le diagnostic des lésions précancéreuses du col utérin. Virologie. 5(6). 431–438. 1 indexed citations
16.
Bergeron, C. & H. Fox. (2000). Low incidence of endometrial hyperplasia with acceptable bleeding patterns in women taking sequential hormone replacement therapy with dydrogesterone. Gynecological Endocrinology. 14(4). 275–281. 12 indexed citations
17.
Lévy, Delphine, et al.. (1997). The Endometrial Approach in Contraception. Annals of the New York Academy of Sciences. 828(1). 59–83. 5 indexed citations
18.
Philip, Thierry, C. Bergeron, & Didier Frappaz. (1996). 8 Management of paediatric lymphoma. Baillière s Clinical Haematology. 9(4). 769–797. 6 indexed citations
20.
Ferenczy, Alex, et al.. (1989). Endometrial response to estrogen-androgen stimulation.. PubMed. 320. 29–40. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026